# Pymaceuticals Inc.
### Findings:
Overall, Capomulin outperformed the placebo and 2 other drugs that were analyzed.
Having had the best response to treatment reducing the tumor volume (mm3) from 45 to 40.72, making the tumor 19% smaller in the course of 45 days. It was the only drug that had any positive affect on the tumor.
It also was the drug that had the lowest number of metastatic sites, about 1.75 less than placebo and Ketaptil.
Lastly, Capomulin had the highest survival rate of over 80%, whereas the other 2 drugs and the placebo all had survival rates below 50%.
